Research location

Basel

Switzerland

Published trials551

Site observations591

Linked trials published551

Page1 / 12

Research activity in Basel

Switzerland

CureCurrent currently publishes aggregate city-level research activity for this location: 551 trials and 591 site observations.

The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.

Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.

Trials with sites in Basel

551 linked trials · page 1 of 12

Overcoming Resistance to Immunotherapy Combining Gemcitabine With Ivonescimab in Advanced NSCLCNCT07158489 · 2026-08-21 · 1 site observation

Magnesium Supplementation in Advanced Non-small Cell Lung Cancer (NSCLC)NCT07149649 · 2026-08-01 · 2 site observations

Stress Reduction Through AcupunctureNCT07132034 · 2026-07-07 · 1 site observation

Copeptin Measurement After Mannitol and Hypertonic Saline for the Diagnosis of Polyuria-polydipsia SyndromeNCT07569861 · 2026-06-16 · 1 site observation

A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast CancerNCT07647328 · 2026-06-15 · 1 site observation

Terbinafine for Biochemically Recurrent Prostate Cancer (TerbinaPro)NCT07365423 · 2026-04-24 · 1 site observation

ABUNDANCE of A NATURAL ODOUR in HUMAN CEREBROSPINAL FLUID AFTER OLFACTORY EXPOSURE - the OLFO-Brain StudyNCT06370845 · 2026-04-14 · 2 site observations

Reduced-dose Carboplatin-doublet-chemotherapy + Cemiplimab vs Cemiplimab Monotherapy in Treatment Naive Older and Frail Patients With Metastatic NSCLC With PD-L1 <50%NCT07020065 · 2026-04-10 · 1 site observation

A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)NCT07361497 · 2026-03-16 · 1 site observation

A Study on the Use of Canakinumab Among Familial Mediterranean Fever and Still's Disease PatientsNCT07517250 · 2026-03-15 · 1 site observation

Postoperative Acute Kidney Injury in Children Undergoing Major Non-cardiac SurgeryNCT07351149 · 2026-03-01 · 1 site observation

Role of Axillary Lymph Node Dissection for Residual MACROMETASTASES After NEOADJUVANT Chemotherapy in Patients With HER2+ and Triple Negative Breast Cancer: The OPBC-11/MACRONAC StudyNCT07546695 · 2026-02-01 · 1 site observation

A Clinical Study to Assess the Efficacy of Adjuvant Immunotherapy With Cemiplimab in Patients With Surgically Removed Non-small Cell Lung Cancer Who Have Not Received Prior ChemotherapyNCT06931717 · 2026-01-12 · 1 site observation

Plasma Oxytocin Response to Oral Estrogens in Healthy Controls and AVP-DeficiencyNCT07361263 · 2026-01-09 · 1 site observation

Plasma Oxytocin Changes in Response to Music Modified by Sonic Augmentation TechnologyNCT07276152 · 2026-01-09 · 1 site observation

Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)NCT07179380 · 2026-01-07 · 1 site observation

Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary SurgeryNCT07140172 · 2026-01-01 · 1 site observation

Early Detection and IntervenTion in Heart FailureNCT07731490 · 2025-12-03 · 1 site observation

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung CancerNCT06793215 · 2025-10-24 · 1 site observation

Trial Investigating Visugromab and Nivolumab With or Without Docetaxel in 2L Treatment of Participants With Metastatic NSCLCNCT07246863 · 2025-10-07 · 1 site observation

Fiber-Boost Randomized Controlled TrialNCT07483112 · 2025-10-07 · 1 site observation

Pilot Observational Study of an Integrative Cure Stay ProgramNCT07398079 · 2025-10-06 · 1 site observation

A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.NCT07053423 · 2025-09-22 · 1 site observation

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast CancerNCT06982521 · 2025-08-26 · 1 site observation

A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) [EMBOLD SCLC-301]NCT07099898 · 2025-08-11 · 1 site observation

Antidepressant Response of DMT Masked With PropofolNCT06927076 · 2025-08-05 · 1 site observation

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or ObesityNCT07037433 · 2025-07-25 · 1 site observation

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular DiseaseNCT07064473 · 2025-07-22 · 1 site observation

Digital Solutions in Heart Therapy (DIGNITY)NCT06942221 · 2025-07-17 · 1 site observation

Effects of Intranasal Oxytocin on Sexual Well-Being in Patients With Arginine Vasopressin Deficiency and Healthy ControlsNCT06808516 · 2025-07-01 · 1 site observation

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and ObesityNCT07037459 · 2025-06-25 · 1 site observation

Effect of Intranasal Oxytocin on Emotion Recognition and Acute Psycho-Social Stress-induced Cortisol Increase in Patients With Central Diabetes Insipidus and Healthy ControlsNCT06676774 · 2025-05-16 · 1 site observation

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)NCT06881784 · 2025-05-06 · 1 site observation

SPYRAL GEMINI Pilot StudyNCT06907147 · 2025-05-01 · 1 site observation

Protein Supplementation in Hyponatremia Due to the Syndrome of Inappropriate AntidiuresisNCT06821802 · 2025-04-14 · 1 site observation

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast CancerNCT06790693 · 2025-04-09 · 1 site observation

Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA TreatmentNCT06750289 · 2025-03-28 · 1 site observation

Ultrasound-guided Cryobiopsy of Mediastinal/Hilar Lymph NodesNCT06921681 · 2025-03-07 · 1 site observation

Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted TherapyNCT06780670 · 2025-02-27 · 1 site observation

Extended vs. No Pelvic Lymph Node Dissection During Radical Prostatectomy. DISSECTION 2.0.NCT06776172 · 2025-02-10 · 1 site observation

Plasma Oxytocin Changes in Response to Low-dose MDMA vs. Placebo in Patients With Arginine Vasopressin Deficiency and Healthy ControlsNCT06789705 · 2025-01-27 · 1 site observation

A Study to Evaluate the Benefit of Adding Durvalumab After Chemotherapy, Durvalumab and Surgery in Patients With Early-stage, Operable, Non-small Cell Lung Cancer.NCT06284317 · 2025-01-15 · 1 site observation

Clinnova-MS: A Prospective Cohort Study of Patients With Multiple Sclerosis (Switzerland)NCT06526364 · 2024-12-10 · 1 site observation

Intratumoral INT230-6 Followed by Neoadjuvant Immuno-chemotherapy in Patients With Early TNBC. INVINCIBLE-4-SAKKNCT06358573 · 2024-10-24 · 1 site observation

A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%NCT06561386 · 2024-10-07 · 1 site observation

Atrial Fibrillation Ablation Versus Atrioventricular Nodal Ablation with Conduction System Pacing in Heart FailureNCT06207383 · 2024-10-01 · 1 site observation

Fibrosis Lessens After Metabolic SurgeryNCT06374875 · 2024-07-11 · 1 site observation

Kesimpta Pregnancy and Infant Safety Study Using Real World DataNCT06156683 · 2024-06-30 · 1 site observation

Targeted Radionuclide Therapy in Metastatic Prostate Cancer Using a New PSMA Ligand Radiolabelled With Terbium-161 (161Tb-SibuDAB) - Dose Identification/Escalation Phase Ia/b StudyNCT06343038 · 2024-02-20 · 1 site observation

REtinal Markers In Neuroinflammatory Diseases ("REMIND")NCT06369766 · 2024-01-31 · 1 site observation

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.